Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MDT Medtronic plc
- Stocks
- Healthcare
- NYSE: MDT
Price (delayed)
$87.195
Market cap
$111.72B
P/E Ratio
24.02
Dividend/share
$2.81
EPS
$3.63
Enterprise value
$138.02B
Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around
Highlights
The EPS rose by 31% year-on-year and by 10% since the previous quarter
The net income has grown by 27% YoY and by 9% from the previous quarter
MDT's debt is up by 14% year-on-year and by 7% since the previous quarter
Medtronic's quick ratio has decreased by 8% YoY
Key stats
What are the main financial stats of MDT
Market
Valuations
Earnings
Shares outstanding
1.28B
Market cap
$111.72B
Enterprise value
$138.02B
Price to earnings (P/E)
24.02
Price to book (P/B)
2.33
Price to sales (P/S)
3.34
EV/EBIT
21.81
EV/EBITDA
15.02
EV/Sales
4.12
Revenue
$33.54B
Gross profit
$21.91B
Operating income
$5.96B
Net income
$4.66B
EBIT
$6.33B
EBITDA
$9.19B
Free cash flow
$5.19B
Per share
Balance sheet
Liquidity
EPS
$3.63
EPS diluted
$3.61
Free cash flow per share
$4.03
Book value per share
$37.44
Revenue per share
$26.09
TBVPS
$29.77
Total assets
$91.68B
Total liabilities
$43.42B
Debt
$28.52B
Equity
$48.02B
Working capital
$10.94B
Debt to equity
0.59
Current ratio
1.85
Quick ratio
1.2
Net debt/EBITDA
2.86
Margins
Efficiency
Dividend
EBITDA margin
27.4%
Gross margin
65.3%
Net margin
13.9%
Operating margin
17.8%
Return on assets
5.2%
Return on equity
9.6%
Return on invested capital
12.3%
Return on capital employed
8%
Return on sales
18.9%
Dividend yield
3.22%
DPS
$2.81
Payout ratio
77.4%
MDT stock price
How has the Medtronic stock price performed over time
Intraday
1.37%
1 week
1.44%
1 month
5.08%
1 year
10.78%
YTD
9.16%
QTD
-2.97%
Financial performance
How have Medtronic's revenue and profit performed over time
Revenue
$33.54B
Gross profit
$21.91B
Operating income
$5.96B
Net income
$4.66B
Gross margin
65.3%
Net margin
13.9%
The net income has grown by 27% YoY and by 9% from the previous quarter
MDT's net margin is up by 22% year-on-year and by 9% since the previous quarter
The operating income has increased by 16% YoY and by 7% QoQ
The operating margin has increased by 12% year-on-year and by 6% since the previous quarter
Price vs fundamentals
How does MDT's price correlate with its fundamentals
Growth
What is Medtronic's growth rate over time
Valuation
What is Medtronic stock price valuation
P/E
24.02
P/B
2.33
P/S
3.34
EV/EBIT
21.81
EV/EBITDA
15.02
EV/Sales
4.12
The EPS rose by 31% year-on-year and by 10% since the previous quarter
The price to earnings (P/E) is 25% lower than the 5-year quarterly average of 31.5 and 9% lower than the last 4 quarters average of 26.1
The stock's price to book (P/B) is 8% less than its 5-year quarterly average of 2.5
The company's equity fell by 4.4% YoY and by 2.8% QoQ
MDT's P/S is 20% lower than its 5-year quarterly average of 4.1
Medtronic's revenue has increased by 3.6% YoY
Efficiency
How efficient is Medtronic business performance
Medtronic's return on equity has increased by 33% YoY and by 10% QoQ
MDT's return on assets is up by 27% year-on-year and by 11% since the previous quarter
The return on sales rose by 11% year-on-year and by 6% since the previous quarter
The company's return on invested capital rose by 10% YoY and by 4.2% QoQ
Dividends
What is MDT's dividend history
DPS
$2.81
Dividend yield
3.22%
Payout ratio
77.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Medtronic financials performed over time
The total assets is 111% greater than the total liabilities
The total liabilities has increased by 10% year-on-year and by 8% since the previous quarter
The company's current ratio fell by 9% YoY and by 2.6% QoQ
MDT's debt is 41% smaller than its equity
Medtronic's debt to equity has increased by 18% YoY and by 9% from the previous quarter
MDT's debt is up by 14% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.